Characteristic odour in the blood reveals ovarian carcinoma

BMC Cancer

Research Article

György Horvath¹  Håkan Andersson²  Gunnar Paulsson² 

[1] Department of Oncology, Sahlgrenska University Hospital, Göteborg, Sweden;Department of Obstetrics and Gynaecology, Skövde City Hospital, Skövde, Sweden;null;

关键词: Ovarian Cancer;    Ovarian Carcinoma;    Electronic Nose;    Borderline Tumour;    Borderline Ovarian Tumour;   

DOI  :  10.1186/1471-2407-10-643

 received in 2010-06-21, accepted in 2010-11-24,  发布年份 2010

来源: Springer

【 摘 要 】

BackgroundOvarian carcinoma represents about 4% of all cancers diagnosed in women worldwide. Mortality rate is high, over 50%, mainly due to late diagnosis. Currently there are no acceptable screening techniques available, although ovarian cancer belongs to the group of malignancies for which mortality could be dramatically reduced by early diagnosis.In a recently published study, we clearly demonstrated that human ovarian carcinoma tissues can be characterized by a specific odour, detectable by a trained dog. Another recent study confirmed these results using an electronic nose.MethodsIn the present work, we examined whether the cancer-specific odour can also be found in the blood. Two specially trained dogs were used. Both ovarian cancer tissues and blood from patients with ovarian carcinoma were tested.ResultsThe tissue tests showed sensitivity of 100% and specificity of 95%, while the blood tests showed sensitivity of 100% and specificity of 98%.ConclusionsThe present study strongly suggests that the characteristic odour emitted by ovarian cancer samples is also present in blood (plasma) taken from patients with the disease. This finding opens possibilities for future screening of healthy populations for early diagnosis of ovarian carcinoma. A future challenge is to develop a sensitive electronic nose for screening of ovarian carcinoma by testing the blood/plasma to detect the disease at a stage early enough for treatment to be effective.

【 授权许可】

CC BY   
© Horvath et al; licensee BioMed Central Ltd. 2010. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.